UnicoCell Biomed Co., Ltd. (TPE:6794)

UnicoCell Biomed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	157.11	9.57	19.9	53.64	130.85	222.02
Short-Term Investments	464.71	518.37	457.38	160.25	10.17	10.09
Trading Asset Securities	20.99	22.3	-	-	-	-
Cash & Short-Term Investments	642.81	550.24	477.28	213.89	141.02	232.11
Cash Growth	40.92%	15.29%	123.15%	51.67%	-39.24%	1.40%
Accounts Receivable	2.42	2.81	2.08	1.38	0.4	0.75
Other Receivables	17.86	19.6	18.08	13.47	12.02	0.11
Receivables	20.28	22.41	20.16	14.84	12.42	0.87
Inventory	8.78	9.75	7.5	7.98	7.83	4.01
Prepaid Expenses	5.04	3.66	1.61	1.13	2.04	14.41
Other Current Assets	4.9	6.29	0.24	0.06	-	0
Total Current Assets	681.79	592.35	506.8	237.9	163.31	251.4
Property, Plant & Equipment	149.33	152.59	175.89	173.36	131.21	132.35
Long-Term Investments	29	29	-	-	-	-
Other Intangible Assets	0.27	0.34	0.33	0.36	0.4	0.78
Other Long-Term Assets	3.47	3.61	2.92	2.7	2.8	6.7
Total Assets	863.87	777.89	685.93	414.31	297.71	391.22
Accounts Payable	0.77	1.97	0.11	0.91	0.08	0.51
Current Portion of Leases	6.25	6.22	6.09	5.93	8.95	10.11
Current Unearned Revenue	2.35	6.62	0.02	1.52	-	-
Other Current Liabilities	10.19	12.32	10.68	8.18	12.34	12.6
Total Current Liabilities	19.56	27.13	16.9	16.54	21.37	23.22
Long-Term Leases	60.44	62.02	68.24	60.66	12.63	23.88
Other Long-Term Liabilities	4.18	4.13	4.35	3.26	0.71	0.71
Total Liabilities	84.18	93.28	89.49	80.46	34.71	47.81
Common Stock	606.11	584.11	556.85	423.61	377.75	375.7
Additional Paid-In Capital	807.28	705.87	551.89	338.43	222.29	218.37
Retained Earnings	-633.71	-605.37	-512.29	-428.19	-337.03	-250.66
Shareholders' Equity	779.69	684.61	596.44	333.85	263.01	343.41
Total Liabilities & Equity	863.87	777.89	685.93	414.31	297.71	391.22
Total Debt	66.69	68.24	74.33	66.59	21.58	33.99
Net Cash (Debt)	576.12	482.01	402.95	147.3	119.44	198.12
Net Cash Growth	50.30%	19.62%	173.56%	23.32%	-39.71%	7.53%
Net Cash Per Share	9.90	8.40	7.49	3.55	3.17	5.58
Filing Date Shares Outstanding	60.61	58.41	55.69	42.36	37.78	37.57
Total Common Shares Outstanding	60.61	58.41	55.69	42.36	37.78	37.57
Working Capital	662.24	565.22	489.9	221.36	141.94	228.18
Book Value Per Share	12.86	11.72	10.71	7.88	6.96	9.14
Tangible Book Value	779.42	684.27	596.12	333.5	262.61	342.63
Tangible Book Value Per Share	12.86	11.71	10.71	7.87	6.95	9.12
Machinery	70.83	70	67.02	65.56	60.92	49.91
Construction In Progress	-	-	-	-	68.3	52.22
Leasehold Improvements	99.39	98.28	97.5	93.25	16.35	16.35

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.